Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Monitoring advanced adenoma and early colorectal cancer by urine metabolomics

ABSTRACT: Interventions: Control Group:none;Advanced Adenoma Group:none;Early Colorectal Cancer Group:none Primary outcome(s): urine metabolomics Study Design: Factorial

DISEASE(S): Advanced Adenoma, Colorectal Cancer

PROVIDER: 2702218 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Json Xml

Similar Datasets

Urine Metabolomics and Colorectal Cancer Screening

Project description:This is a prospective, multi-centered study to assess whether urine metabolomics can play a role in the screening of colorectal cancer (CRC). Urine samples will be collected from 1000 patients going through an established CRC screening program, and from a further 500 patients who already have a diagnosis of CRC. Using nuclear magnetic resonance (NMR) spectroscopy, the 1H NMR spectrum of urine samples will be analyzed for specific metabolites, and establish the metabolomic signature of colorectal cancer. The results from metabolomic urinalysis of this screening cohort will be compared with results from colonoscopy, histological descriptions, fecal occult blood testing (FOBT), and fecal immune testing (FIT) to assess the accuracy of urine metabolomics in identifying patients with polyps and malignancies. The urine metabolomic results from the colorectal cancer group will be correlated with operative, histological and clinical staging to define the role of urine metabolomics in assessing colorectal cancer type, location and stage. Additionally approximately 300 urine samples from breast cancer patients and 300 from prostate cancer patients will be collected to validate that the colorectal cancer signature is unique.

| 2116822 | ecrin-mdr-crc

LC-MS-based urine metabolomics analyses for early diagnosis of medulloblastoma

Project description:we applied liquid chromatography - mass spectrometry (LC-MS) based metabolomics to analyze a cohort including 420 urine samples

2019-11-27 | PXD016453 |

Effect of intestinal microbiome diversity on the efficacy and survival of chemotherapy for advanced non-small cell lung cancer

Project description:Interventions: Response Group:none;None Response Group:Nil Primary outcome(s): CR;PR;SD;PD;PFS;OS;Gut microbiome;Fecal metabolomics;Immune factor Study Design: Factorial

| 2689133 | ecrin-mdr-crc

Mining the Human Urine Proteome for Monitoring Renal Transplant Injury

Project description:Gene expression data was analyzed to map with urine proteomics data gene expression data from kidney biopsies from kidney transplant patients with and without acute rejection, chronic allograft nephropathy and BK virus nephritis was used to study gene expression changes during acute rejection, chronic allograft nephropathy and bk virus nephropathy. Samples labeled STA16, STA22, STA14, and STA18 were included in the CAN vs no-CAN analysis as no-CAN samples as they also qualified as non-CAN samples.

2017-08-22 | GSE75693 | GEO

UPLC-MS based urine metabolomics for bladder cancer diagnosis and grading

Project description:In our study, we collected urine samples from 246 cases, including 131 BC patients, 27 benign bladder disease patients, and 88 healthy adults as the control group. Ultra-performance liquid chromatography coupled to mass spectrometry (UPLC-MS) was applied for urine metabolomics analysis to distinguish the BC group from the healthy controls and the benign group, and the low-grade BC group from the high-grade BC group.

2024-11-27 | PXD058310 |

Real-time health monitoring through urine metabolomics.

Project description:Current healthcare practices are reactive and based on limited physiological information collected months or years apart. By enabling patients and healthy consumers access to continuous measurements of health, wearable devices and digital medicine stand to realize highly personalized and preventative care. However, most current digital technologies provide information on a limited set of physiological traits, such as heart rate and step count, which alone offer little insight into the etiology of most diseases. Here we propose to integrate data from biohealth smartphone applications with continuous metabolic phenotypes derived from urine metabolites. This combination of molecular phenotypes with quantitative measurements of lifestyle reflect the biological consequences of human behavior in real time. We present data from an observational study involving two healthy subjects and discuss the challenges, opportunities, and implications of integrating this new layer of physiological information into digital medicine. Though our dataset is limited to two subjects, our analysis (also available through an interactive web-based visualization tool) provides an initial framework to monitor lifestyle factors, such as nutrition, drug metabolism, exercise, and sleep using urine metabolites.

| S-EPMC6848197 | biostudies-literature

Urine

Project description:Urine Raw sequence reads

| PRJNA850668 | ENA

Exploring the effect of different surgical methods on the prognosis of patients with colorectal cancer based on multiple omics

Project description:Interventions: left hemicolectomy:None;right hemicolectomy:None;sigmoid resection:None;radical rectal cancer:None;low rectal resection with prophylactic ileostomy:None Primary outcome(s): Fecal high-throughput sequencing;Fecal Metabolomics;immunomics Study Design: Factorial

| 85716 | ecrin-mdr-crc

urine metagenome

Project description:urine metagenome Metagenome

| PRJNA1032262 | ENA

Podocyte-released migrasomes in urine serve as an indicator for early podocyte injury

Project description:miRNA microarray was performed for migrasomes and exosomes derived from urine

2020-05-14 | GSE150459 | GEO